Uncontrolled growth resulting from dedifferentiation in a skin cell proliferation model.
Phys Rev E Stat Nonlin Soft Matter Phys., Apr;85(4 Pt 1):041926 (2012)
Effects of HB-EGF and epiregulin on wound healing of gingival cells in vitro.
Oral Dis., Nov;17(8):785-93 (2011)
Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of BehÃ§et's disease.
Br. J. Dermatol., Mar;158(3):505-11 (2008)
Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Biochemistry., Jan;38(4):1185-92 (1999)
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
J. Clin. Invest., Aug;100(4):886-92 (1997)
Factor VIIa-tissue factor interactions: an evaluation using factor VII-factor IX chimeras.
Haemostasis., 26 Suppl 1:35-9 (1996)
The roles of factor VII's structural domains in tissue factor binding.
Biochemistry., Sep;34(38):12227-32 (1995)
The disulfide folding pathway of human epidermal growth factor.
J. Biol. Chem., Apr;270(16):9207-16 (1995)
Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.
Transplant. Proc., Feb;23(1 Pt 1):868-9 (1991)
On the dermal absorption of cocaine.
J Anal Toxicol., 14(6):383-4 (1990 Nov-Dec)
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades--should peripheral T-cell lymphoma be considered separately?
J. Clin. Oncol., Jun;7(6):725-31 (1989)
Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.
Agents Actions., Mar;26(3-4):319-28 (1989)